[Retracted] The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy‐Induced Thrombocytopenia

Wenxian Wang, Xiaodong Gu, Lan Shao, Zhiyong Shi, Guangyuan Lou, Zhengbo Song, Yiping Zhang

DOI: 10.1155/2022/2256690
Published: 2022-01
Container: Contrast Media & Molecular Imaging
Publisher: Wiley
Open access: unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1155/2022/2256690,
  title = {[Retracted] The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy‐Induced Thrombocytopenia},
  author = {Wenxian Wang and Xiaodong Gu and Lan Shao and Zhiyong Shi and Guangyuan Lou and Zhengbo Song and Yiping Zhang},
  year = {2022},
  journal = {Contrast Media \&amp; Molecular Imaging},
  doi = {10.1155/2022/2256690},
  url = {https://doi.org/10.1155/2022/2256690}
}

RIS

TY  - JOUR
TI  - [Retracted] The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy‐Induced Thrombocytopenia
AU  - Wenxian Wang
AU  - Xiaodong Gu
AU  - Lan Shao
AU  - Zhiyong Shi
AU  - Guangyuan Lou
AU  - Zhengbo Song
AU  - Yiping Zhang
PY  - 2022
JO  - Contrast Media &amp; Molecular Imaging
DO  - 10.1155/2022/2256690
UR  - https://doi.org/10.1155/2022/2256690
ER  -

APA

Wang, W., Gu, X., Shao, L., Shi, Z., Lou, G., Song, Z., & Zhang, Y. (2022). [Retracted] The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy‐Induced Thrombocytopenia. Contrast Media & Molecular Imaging. https://doi.org/10.1155/2022/2256690

Source records

crossref · retrieved 2026-09-25T02:24:19.358Z